OA09898A - Solutions aqueuses de doxorubicine. - Google Patents

Solutions aqueuses de doxorubicine.

Info

Publication number
OA09898A
OA09898A OA59689A OA59689A OA09898A OA 09898 A OA09898 A OA 09898A OA 59689 A OA59689 A OA 59689A OA 59689 A OA59689 A OA 59689A OA 09898 A OA09898 A OA 09898A
Authority
OA
OAPI
Prior art keywords
doxorubicin
aqueous solutions
physiologically acceptable
solutions
antioxidant
Prior art date
Application number
OA59689A
Other languages
English (en)
Inventor
Murray Kaplan
Robert Perrone
Joseph Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of OA09898A publication Critical patent/OA09898A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
OA59689A 1988-12-05 1989-12-04 Solutions aqueuses de doxorubicine. OA09898A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27962788A 1988-12-05 1988-12-05

Publications (1)

Publication Number Publication Date
OA09898A true OA09898A (fr) 1994-09-15

Family

ID=23069771

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59689A OA09898A (fr) 1988-12-05 1989-12-04 Solutions aqueuses de doxorubicine.

Country Status (20)

Country Link
EP (1) EP0372888B1 (fr)
JP (1) JPH02200637A (fr)
KR (1) KR920001460B1 (fr)
AT (1) ATE78402T1 (fr)
AU (1) AU612916B2 (fr)
DD (1) DD295990A5 (fr)
DE (1) DE68902223T2 (fr)
DK (1) DK609889A (fr)
ES (1) ES2044148T3 (fr)
FI (1) FI895733A0 (fr)
GR (1) GR3005391T3 (fr)
HU (1) HU204704B (fr)
IE (1) IE893867L (fr)
IL (1) IL92541A0 (fr)
NO (1) NO894811L (fr)
NZ (1) NZ231602A (fr)
OA (1) OA09898A (fr)
PT (1) PT92483B (fr)
YU (1) YU226189A (fr)
ZA (1) ZA899248B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
US11213538B2 (en) 2016-02-16 2022-01-04 General Incorporated Association Pharma Valley Project Supporting Organization Agent for overcoming immunosuppression and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.

Also Published As

Publication number Publication date
KR900009081A (ko) 1990-07-02
DD295990A5 (de) 1991-11-21
ZA899248B (en) 1990-08-29
PT92483B (pt) 1995-08-09
ES2044148T3 (es) 1994-01-01
PT92483A (pt) 1990-06-29
NZ231602A (en) 1991-12-23
HUT52961A (en) 1990-09-28
AU4591589A (en) 1990-06-07
AU612916B2 (en) 1991-07-18
NO894811L (no) 1990-06-06
EP0372888B1 (fr) 1992-07-22
HU896426D0 (en) 1990-02-28
ATE78402T1 (de) 1992-08-15
FI895733A0 (fi) 1989-11-30
DK609889A (da) 1990-06-06
DE68902223T2 (de) 1993-01-14
KR920001460B1 (ko) 1992-02-14
EP0372888A1 (fr) 1990-06-13
NO894811D0 (no) 1989-12-01
YU226189A (en) 1991-02-28
GR3005391T3 (fr) 1993-05-24
IE893867L (en) 1990-06-05
JPH02200637A (ja) 1990-08-08
IL92541A0 (en) 1990-08-31
DE68902223D1 (de) 1992-08-27
DK609889D0 (da) 1989-12-04
HU204704B (en) 1992-02-28

Similar Documents

Publication Publication Date Title
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
NO853075L (no) Fremgangsmaate for fremstilling av s-adenosyl-l-metionin (sam) salter.
SE8402549D0 (sv) Substituerade moranolinderivat
AU8889891A (en) Pharmaceutical compositions
ES2033379T3 (es) Soluciones acuosas de clorhidrato de doxorubicina.
OA09898A (fr) Solutions aqueuses de doxorubicine.
AU6246690A (en) Protein-containing aqueous solutions
ATE87210T1 (de) Doxorubicin-loesungen.
IE780164L (en) Salts of benzopyrans
AU528128B2 (en) Sparingly water-soluble salts of pencillanic acid 1,1- dioxide
DK214884A (da) Chlorphenoxyacetatderivat